Related content

Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease

By Miller G.W.   Erickson J.D.   Perez J.T.   Penland S.N.   Mash D.C.   Rye D.B.   Levey A.I.  

Experimental Neurology, Vol. 156, Iss. 1, 1999-03 ,pp. : 138-148

Elsevier

Access to resources Recommend Favorite

Brain Region-Specific Effects of Short-Term Treatment with Duloxetine, Venlafaxine, Milnacipran and Sertraline on Monoamine Metabolism in Rats

By Muneoka Katsumasa   Shirayama Yukihiko   Takigawa Morikuni   Shioda Seiji  

Neurochemical Research, Vol. 34, Iss. 3, 2009-03 ,pp. : 542-555

Springer Publishing Company

Access to resources Recommend Favorite

Elevated platelet vesicular monoamine transporter 2 in former heroin addicts maintained on methadone

By Schwartz K.   Herman I.   Peer G.   Weizman A.   Rehavi M.  

Journal of Neural Transmission, Vol. 114, Iss. 2, 2007-02 ,pp. : 281-284

Springer Publishing Company

Access to resources Recommend Favorite

The Dopamine Transporter Expression Level Differentially Affects Responses to Cocaine and Amphetamine

By Cagniard Barbara   Sotnikova Tatyana D.   Gainetdinov Raul R.   Zhuang Xiaoxi  

Journal of Neurogenetics, Vol. 28, Iss. 1-2, 2014-06 ,pp. : 112-121

Informa Healthcare

Access to resources Recommend Favorite

Chronic Effects of Traumatic Brain Injury on Hippocampal Vesicular Acetylcholine Transporter and M 2 Muscarinic Receptor Protein in Rats

By Ciallella J.R.   Yan H.Q.   Ma X.   Wolfson B.M.   Marion D.W.   DeKosky S.T.   Dixon C.E.  

Experimental Neurology, Vol. 152, Iss. 1, 1998-07 ,pp. : 11-19

Elsevier

Access to resources Recommend Favorite